Talent
Efficient and rigorous team collaboration capabilities
Scientific staff training system
Our Company
We are an R&D-driven, AI-powered biopharmaceutical company dedicated to improving lives and delivering sustainable growth.
Our Pipeline
We are advancing six pipelines in innovative drug development targeting Alzheimer’s disease, type 2 diabetes, obesity, depression, and anxiety.
Our Patent
Our company is dedicated to tackling some of the world’s most urgent health challenges—Alzheimer’s disease, obesity, and diabetes.
With a strong portfolio of patents, we deliver cutting-edge solutions that move beyond conventional treatments.
In Alzheimer’s disease, our proprietary technologies aim to enhance cognitive function through novel, targeted mechanisms.
For obesity and diabetes, we have developed breakthrough approaches that optimize key proteins, offering results similar to GLP-1 therapies—helping to regulate blood sugar and support effective weight management.
These innovations reflect our commitment to transforming scientific discovery into meaningful health outcomes, shaping a healthier future for patients worldwide.
Our Advantages
Market
Pioneering blue ocean drug R&D in anti-aging, appetite control, and antidepressants
Unique advantages in entering overseas markets
Technology
Big Data and AI to Discover Unique Drug Targets
Unique peptide modification technology
News
View all news
Recruitment, Join us to redefine medicine
Arviva Therapeutics Inc. is an R&D-driven, AI-powered biopharmaceutical company dedicated to pioneering the next generation of innovative therapies. We focus on developing treatmen
Read article : Recruitment, Join us to redefine medicine
GLP-1 The Key Behind Weight Loss
Obesity is a sub-health issue that plagues many people today, and the history of humanity's struggle with obesity is also the history of the development of weight-loss drugs.
Read article : GLP-1 The Key Behind Weight Loss
Appetite Remote Control in the Gut How Specific Microbiota Regulate Brain Feeding Behavior
Microbiota in the gut are most abundant in the colon and largely regulate feeding behavior, possibly through neuroregulators, immune signals, and the vagal nerve pathway. However,
Read article : Appetite Remote Control in the Gut How Specific Microbiota Regulate Brain Feeding Behavior
Hypotheses of Alzheimer’s Disease (AD) Pathogenesis
Currently, researchers have proposed several hypotheses regarding the pathogenesis of Alzheimer’s disease (AD). However, due to the complexity and heterogeneity of AD pathology, co
Read article : Hypotheses of Alzheimer’s Disease (AD) PathogenesisContact
Address
Irving Warehouse-207204
100 Circle Road, Ammann-C111
Stony Brook, NY 11790-3607
Phone6175153053
EmailBD@arvivatherap.com
Websitearvivatherap.com